Related Experiment Videos
Exchange transfusion in sickle cell disease using a continuous-flow blood cell separator
Transfusion
|May 1, 1977
Summary
Continuous-flow blood cell separators provide a safe and effective method for exchange transfusion in patients with sickle cell disease. This procedure successfully increased hemoglobin A levels to 90.8% preoperatively.
Area of Science:
- Hematology
- Medical Devices
- Surgical Procedures
Background:
- Sickle cell disease (SCD) is a genetic blood disorder requiring management of complications.
- Preoperative interventions are crucial for managing patients with SCD undergoing surgery.
- Exchange transfusion is a therapeutic option for SCD patients.
Purpose of the Study:
- To evaluate the efficacy and safety of continuous-flow blood cell separators for preoperative exchange transfusion in a patient with sickle cell disease.
Main Methods:
- A preoperative exchange transfusion was performed using a continuous-flow blood cell separator.
- A total of 2,825 ml of red blood cells were exchanged.
Main Results:
- The exchange transfusion successfully achieved a hemoglobin A (HbA) level of 90.8%.
- The procedure was performed without reported complications.
Conclusions:
- Continuous-flow blood cell separators are a safe and effective tool for performing exchange transfusions in patients with sickle cell disease.
- This method facilitates preoperative optimization in SCD patients, potentially reducing surgical risks.